Search Details

Word: contracted (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

Meanwhile, Leon Falic is trying to reassure his couturier. "I understand if he is nervous," Falic says of Lacroix, who still has to negotiate a contract with his new owners. "I think he will be very happy with us. We are very direct people. We're accessible. It's a family company, and we are all very family oriented." And unlike most fashion "families," still fully functional. --Reported by Sarah Raper Larenaudie/Paris

Author: /time Magazine | Title: Crisis on the Catwalk | 1/31/2005 | See Source »

Katie Couric A network source tells TIME the Today show co-anchor has been approached about the job. If she could be persuaded to jump, CBS would have to wait 16 months--when her NBC contract is up. But the network could name an old hand like Face the Nation's Bob Schieffer or Early Show host Harry Smith as a caretaker until then...

Author: /time Magazine | Title: Goodbye, Dan. Hello, Katie? | 1/24/2005 | See Source »

...Koppel The Nightline king's contract ends later this year, and CBS is rumored to be interested in him. But would the ABC vet want the job? At least he wouldn't have to worry about competing with Letterman...

Author: /time Magazine | Title: Goodbye, Dan. Hello, Katie? | 1/24/2005 | See Source »

Cleveland is also begging James to stick by the Cavs; his bargain rookie contract ($18.8 million for four years) ends in 2007. Dan Gilbert, founder of online lender Quicken Loans, is forking over $375 million to buy the Cavs from longtime owner Gordon Gund. Gilbert says he'll do whatever it takes to keep James. Although James says, "I don't want to go anywhere else to play," it will probably take Kobe money, somewhere north of $130 million for a seven-year deal, to make him stay. The city is starving for a winner--Cleveland has gone 41 years...

Author: /time Magazine | Title: King James | 1/23/2005 | See Source »

...fragment of what could eventually become an Alzheimer's-conquering drug. "I first thought the team had played a trick on me," says Jhoti. Drug giant AstraZeneca, which had been searching for such a chemical for years, enlisted Astex's help. In 2003 the company signed a contract to pay Astex $40 million if Astex hits milestone breakthroughs and to make royalty payments once AstraZeneca sells drugs based on Astex's technology. "AstraZeneca worked on it for four years. We delivered an early candidate within a year of signing with them," says Jhoti. He also hopes to win regulatory approval...

Author: /time Magazine | Title: Innovation: Tech Pioneers | 1/23/2005 | See Source »

Previous | 279 | 280 | 281 | 282 | 283 | 284 | 285 | 286 | 287 | 288 | 289 | 290 | 291 | 292 | 293 | 294 | 295 | 296 | 297 | 298 | 299 | Next